These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 12067227

  • 41. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sawada H, Hishida R, Hirata Y, Ono K, Suzuki H, Muramatsu S, Nakano I, Nagatsu T, Sawada M.
    J Neurosci Res; 2007 Jun; 85(8):1752-61. PubMed ID: 17469135
    [Abstract] [Full Text] [Related]

  • 42. Biochanin A Protects Against Lipopolysaccharide-Induced Damage of Dopaminergic Neurons Both In Vivo and In Vitro via Inhibition of Microglial Activation.
    Wang J, Wu WY, Huang H, Li WZ, Chen HQ, Yin YY.
    Neurotox Res; 2016 Oct; 30(3):486-98. PubMed ID: 27417698
    [Abstract] [Full Text] [Related]

  • 43. Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease.
    Breidert T, Callebert J, Heneka MT, Landreth G, Launay JM, Hirsch EC.
    J Neurochem; 2002 Aug; 82(3):615-24. PubMed ID: 12153485
    [Abstract] [Full Text] [Related]

  • 44. β-Amyrin, the cannabinoid receptors agonist, abrogates mice brain microglial cells inflammation induced by lipopolysaccharide/interferon-γ and regulates Mφ1/Mφ2 balances.
    Askari VR, Fereydouni N, Baradaran Rahimi V, Askari N, Sahebkar AH, Rahmanian-Devin P, Samzadeh-Kermani A.
    Biomed Pharmacother; 2018 May; 101():438-446. PubMed ID: 29501766
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease.
    Chung YC, Kim SR, Jin BK.
    J Immunol; 2010 Jul 15; 185(2):1230-7. PubMed ID: 20566832
    [Abstract] [Full Text] [Related]

  • 50. Pro-inflammatory cytokine-mediated ferroportin down-regulation contributes to the nigral iron accumulation in lipopolysaccharide-induced Parkinsonian models.
    Zhang Z, Hou L, Song JL, Song N, Sun YJ, Lin X, Wang XL, Zhang FZ, Ge YL.
    Neuroscience; 2014 Jan 17; 257():20-30. PubMed ID: 24183966
    [Abstract] [Full Text] [Related]

  • 51. Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra.
    Arimoto T, Choi DY, Lu X, Liu M, Nguyen XV, Zheng N, Stewart CA, Kim HC, Bing G.
    Neurobiol Aging; 2007 Jun 17; 28(6):894-906. PubMed ID: 21887889
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. In vivo expression of cyclooxygenase-2 in rat brain following intraparenchymal injection of bacterial endotoxin and inflammatory cytokines.
    Minghetti L, Walsh DT, Levi G, Perry VH.
    J Neuropathol Exp Neurol; 1999 Nov 17; 58(11):1184-91. PubMed ID: 10560661
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. LPS-induced degeneration of dopaminergic neurons of substantia nigra in rats.
    Li G, Sun S, Cao X, Zhong J, Tong E.
    J Huazhong Univ Sci Technolog Med Sci; 2004 Nov 17; 24(1):83-6. PubMed ID: 15165124
    [Abstract] [Full Text] [Related]

  • 56. Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally.
    Ling Z, Zhu Y, Tong Cw, Snyder JA, Lipton JW, Carvey PM.
    Exp Neurol; 2006 Jun 17; 199(2):499-512. PubMed ID: 16504177
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation.
    Hurelbrink CB, Armstrong RJ, Luheshi LM, Dunnett SB, Rosser AE, Barker RA.
    Exp Neurol; 2001 Sep 17; 171(1):46-58. PubMed ID: 11520120
    [Abstract] [Full Text] [Related]

  • 59. Silibinin attenuates MPP⁺-induced neurotoxicity in the substantia nigra in vivo.
    Jung UJ, Jeon MT, Choi MS, Kim SR.
    J Med Food; 2014 May 17; 17(5):599-605. PubMed ID: 24660866
    [Abstract] [Full Text] [Related]

  • 60. Meloxicam reduces lipopolysaccharide-induced degeneration of dopaminergic neurons in the rat substantia nigra pars compacta.
    Sui Y, Stanić D, Tomas D, Jarrott B, Horne MK.
    Neurosci Lett; 2009 Aug 28; 460(2):121-5. PubMed ID: 19450656
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.